PROFOUND MEDICAL CORP. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019
PROFOUND MEDICAL CORP. (PROF) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 of 16.19 CAD/shares as of 2023-12-31, per its 40-F filed 2024-03-07.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 · last filed 2024-03-07
- 2023-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 16.19 CAD/shares.
- 2022-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 16.07 CAD/shares.
- 2021-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 16.90 CAD/shares.
- 2020-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 14.05 CAD/shares.
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 |
|---|---|
| 2023-12-31 | 16.19 CAD/shares 40-F · filed 2024-03-07 |
| 2022-12-31 | 16.07 CAD/shares 40-F · filed 2024-03-07 |
| 2021-12-31 | 16.90 CAD/shares 40-F · filed 2024-03-07 |
| 2020-12-31 | 14.05 CAD/shares 40-F · filed 2023-03-07 |
| 2019-12-31 | 10.51 CAD/shares 40-F · filed 2020-03-03 |
| 2018-12-31 | 11.34 CAD/shares 40-F · filed 2020-03-03 |
| 2017-12-31 | 10.90 CAD/shares 40-F · filed 2020-03-03 |
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 as first filed |
|---|---|---|
| 2021-12-31 | $16.90 40-F · filed 2022-03-03 | |
| 2020-12-31 | $14.05 40-F · filed 2022-03-03 | $10.97 40-F · filed 2021-03-02 |
| 2019-12-31 | $10.51 40-F · filed 2022-03-03 | $8.09 40-F · filed 2021-03-02 |
| 2018-12-31 | $8.34 40-F · filed 2021-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |